The red cell transfusion trigger: Has a sin of commission now become a sin of omission?

Transfusion

Volumn 38, Issue 6, 1998, Pages 602-610

  Valeri, C R ^a   Crowley, J P ^b,c   Loscalzo, J ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BROWN UNIVERSITY   (United States)

^c BROWN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NITRIC OXIDE;

ANEMIA; BLOOD VOLUME; ERYTHROCYTE TRANSFUSION; ERYTHROCYTE VOLUME; HEART OUTPUT; HUMAN; HUMAN CELL; HUMAN TISSUE; REVIEW; SHEAR STRESS;

EID: 0031820606     PISSN: 00411132     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1537-2995.1998.38698326341.x     Document Type: Review

References (100)

1. Surgenor DM, Wallace EL, Hale SG, Gilpatrick MW. Changing patterns of blood transfusions in four sets of United States hospitals, 1980 to 1985. Transfusion 1988;28:513-8.
2. Surgenor DM, Wallace EL, Hao SH, Chapman RH. Collection and transfusion of blood in the United States, 1982-1988. N Engl J Med 1990;322:1646-51.
3. Wallace EL, Churchill WH, Surgenor DM, et al. Collection and transfusion of blood and blood components in the United States, 1992. Transfusion 1995;35:802-12.
4. Consensus conference. Perioperative red blood cell transfusion. JAMA 1988;260:2700-3.
5. Dodd RY. The risk of transfusion-transmitted infections (editorial). N Engl J Med 1992;327:419-21.
6. Schreiber GB, Busch MP, Kleinman SH, Korelitz JJ. The risk of transfusion-transmitted viral infections. N Engl J Med 1996;334:1685-90.
7. Holland PV. Viral infections and the blood supply (editorial; comment). N Engl J Med 1996;334:1734-5.
8. Kitchens CS. Are transfusions overrated: surgical outcome of Jehovah's Witnesses. Am J Med 1993;94:117-9.
9. Viele MK, Weiskopf RB. What can we learn about the need for transfusion from patients who refuse blood? The experience with Jehovah's Witnesses. Transfusion 1994;34:396-401.
10. Ashton CM, Petersen NJ, Wray NP, et al. The incidence of perioperative myocardial infarction in men undergoing noncardiac surgery. Ann Intern Med 1993;118:504-10.
11. Czer LSC, Shoemaker WC. Optimal hematocrit value in critically ill postoperative patients. Surg Gynecol Obstet 1978;147:363-8.
12. Rawstron RE. Anaemia and surgery: a retrospective clinical study. Aust N Z J Surg 1980;39:425-32.
13. Friedman BA, Burns TL, Schork MA. An analysis of blood transfusion of surgical patients by sex: a quest for the transfusion trigger. Transfusion 1980;20:179-88.
14. Carson JL, Poses RM, Spence RK, Bonavita G. Severity of anaemia and operative mortality and morbidity. Lancet 1988;1:727-9.
15. Salem-Schatz SR, Avorn J, Soumerai SB. Influence of clinical knowledge, organizational context and practice style on transfusion decision making. Implications for practice change strategies. JAMA 1990;264:476-83.
16. Mangano DT, Browner WS, Hollenberg M, et al. Association of perioperative myocardial ischemia with cardiac morbidity and mortality in men undergoing noncardiac surgery. N Engl J Med 1990;323:1781-8.
17. Carson JL, Willet LR. Is a hemoglobin of 10 g/dL required for surgery? Med Clin North Am 1993;77:335-47.
18. Nelson AH, Fleisher LA, Rosenbaum SH. Relationship between postoperative anemia and cardiac morbidity in high risk vascular patients in the intensive care unit. Crit Care Med 1993;21:860-6.
19. Hebert PC, Wells G, Marshall J, et al. Transfusion requirements in critical care. A pilot study. JAMA 1995;273:1439-44.
20. Carson JL, Duff A, Poses RM, et al. Effect of anaemia and cardiovascular disease on surgical mortality and morbidity. Lancet 1996;348:1055-60.
21. Hebert PC, Wells G, Tweeddale M, et al. Does transfusion practice affect mortality in critically ill patients? Am J Respir Crit Care Med 1997;155:1618-23.
22. Finch CA, Lenfant C. Oxygen transport in man. N Engl J Med 1972;286:407-15.
23. Valeri CR. Physiology of blood transfusion. In: Barie PS, Shires GT, eds. Surgical intensive care. Boston: Little, Brown, 1993:681-721.
24. Valeri CR. Transfusion medicine and surgical practice. Bull Am Coll Surg 1993;78:20-4.
25. 125I serum albumin. Arch Intern Med 1973;132:534-43.
26. Jones J, Mollison PL. A simple and efficient method of labelling red cells with 99mTc for determination of red cell volume. Br J Haematol 1978;38:141-8.
27. Valeri CR, Altschule MD. Hypovolemic anemia of trauma: the missing blood syndrome. Boca Raton, FL: Chemical Rubber Company Press, 1981.
28. Biron PE, Howard J, Aetschule MD, Valeri CR. Chronic deficits in red-cell mass in patients with orthopaedic injuries (stress anemia). J Bone Joint Surg [Am] 1972;54:1001-14.
29. Magnusson B, Hallberg L, Rossander L, Swolin B. Iron metabolism and "sports anemia". 1. A study of several iron parameters in elite runners with differences in iron status. Acta Med Scand 1984;216:149-55.
30. Valeri CR, Donahue K, Feingold HM, et al. Increase in plasma volume after the transfusion of washed erythrocytes. Surg Gynecol Obstet 1986;162:30-6.
31. Birchard GF. Optimal hematocrit: Theory, regulation and implications. Am Zool 1997;37:65-72.
32. Stehling L, Zauder HL. Acute normovolemic hemodilution. Transfusion 1991;31:857-68.
33. Fisher JB, Dennis RC, Valeri CR, et al. Effect of graft material on loss of erythrocytes after aortic operations. Surg Gynecol Obstet 1991;173:131-6.
34. Cordts PR, LaMorte WW, Fisher JB, et al. Poor predictive value of hematocrit and hemodynamic parameters for erythrocyte deficits after extensive elective vascular operations. Surg Gynecol Obstet 1992;175:243-8.
35. Deitch EA, Berg RD. Bacterial translocation from the gut: A mechanism of infection. J Burn Care Rehabil 1987;8:475-82.
36. Marik P. Gastric intramucosal pH. A better predictor of multiorgan dysfunction and death than oxygen derived variables in patients with sepsis. Chest 1993;104:225-9.
37. Ivatury R, Simon J, Islam S, et al. A prospective randomized study of end points of resuscitation after major trauma: global oxygen transport indices versus organ specific gastric mucosal pH. J Am Coll Surg 1996;183:145-54.
38. Valeri CR, Collins FB. Physiologic effects of 2,3-DPG-depleted red cells with high affinity for oxygen. J Appl Physiol 1971;31:823-7.
39. Szymanski IO, Valeri CR. Automated differential agglutination technic to measure red cell survival. II. Survival in vivo of preserved red cells. Transfusion 1968;8:74-83.
40. Edwards A, Richardson C, Van der Zee P, et al. Measurement of hemoglobin flow and blood flow by near infrared spectroscopy. J Appl Physiol 1993;75:1884-9.
41. DeBlasi R, Ferrari M, Natali A, et al. Noninvasive measurement of forearm blood flow and oxygen consumption by near-infrared spectroscopy. J Appl Physiol 1994;76:1388-93.
42. Hellem AJ, Borchgrevink CF, Ames SB. The role of red cells in hemostasis: the relation between hematocrit, bleeding time and platelet adhesiveness. Br J Haematol 1961;7:42-50.
43. Hopkins RW, Fratianne RB, Rao KV, Damewood CA. Effects of hematocrit and viscosity on continuing hemorrhage. J Trauma 1975;14:482-93.
44. Boneu B, Fernandez F. The role of the hematocrit in bleeding. Transfus Med Rev 1987;1:182-5.
45. Gerrard JM, Docherty JC, Israels SJ, et al. A reassessment of the bleeding time: association of age, hematocrit, platelet function, von Willebrand factor, and bleeding time thromboxane B2 with the length of the bleeding time. Clin Invest Med 1989;12:165-71.
46. Cadroy Y, Hanson SR. Effects of red blood cell concentration on hemostasis and thrombus formation in a primate model. Blood 1990;75:2185-93.
47. DeCaterina R, Lanza M, Manca G, et al. Bleeding time and bleeding: an analysis of the relationship of the bleeding time test with parameters of surgical bleeding. Blood 1994;84:3363-70.
48. Blajchman MA, Bordin JO, Bardossy L, Heddle NM. The contribution of the haematocrit to thrombocytopenic bleeding in experimental animals. Br J Haematol 1994;86:347-50.
49. Anand A, Feffer SE. Hematocrit and bleeding time: an update. South Med J 1994;87:299-301.
50. Crowley JP, Metzger JB, Valeri CR. The volume of blood shed during the bleeding time correlates with the peripheral venous hematocrit. Am J Clin Pathol 1997;108:579-84.
51. Livio M, Gotti E, Marchesi D, et al. Uremic bleeding: role of anemia and beneficial effect of red cell transfusions. Lancet 1982;2:1013-5.
52. Fernandez F, Goudable C, Sie P, et al. Low haematocrit and prolonged bleeding time in uraemic patients: effect of red cell transfusions. Br J Haematol 1985;59:139-48.
53. Moia M, Mannucci PM, Vizzotto L, et al. Improvement in the haemostatic defect of uraemia after treatment with recombinant human erythropoietin. Lancet 1987;2:1227-9.
54. Akizawa T, Kinugasa E, Kitaoka T, Koshikawa S. Effects of recombinant human erythropoietin and correction of anemia on platelet function in hemodialysis patients. Nephron 1991;58:400-6.
55. Zwaginga JJ, Ijsseldijk MJ, deGroot PG, et al. Treatment of uremic anemia with recombinant erythropoietin also reduces the defects in platelet adhesion and aggregation caused by uremic plasma. Thromb Haemost 1991;66:638-47.
56. Duke WW. The relation of blood platelets to hemorrhagic disease. JAMA 1910;60:1185-92.
57. Harker LA, Slichter SJ. The bleeding time as a screening test for the evaluation of platelet function. N Engl J Med 1972;287:155-9.
58. Rodgers RP, Levin J. A critical reappraisal of the bleeding time. Semin Thromb Hemost 1991;16:1-20.
59. Lind SE. The bleeding time does not predict surgical bleeding. Blood 1991;77:2547-52.
60. Khuri SF, Wolfe JA, Josa M, et al. Hematologic changes during and following cardiopulmonary bypass and their relationship to non-surgical blood loss. J Thorac Cardiovasc Surg 1992;104:94-107.
61. Remuzzi G, Livio M, Marchiaro G, et al. Bleeding in renal failure: altered platelet function in chronic uraemia only partially corrected by haemodialysis. Nephron 1978;22:347-53.
62. Tsao CJ, Kao RH, Cheng TY, et al. The effect of recombinant human erythropoietin on hemostatic status in chronic uremic patients. Int J Hematol 1992;55:197-203.
63. Remuzzi G. Bleeding in renal failure. Lancet 1988;1:1205-8.
64. Zwaginga JJ, Ijsseldijk MJ, deGroot PG, et al. Defects in platelet adhesion and aggregate formation in uremic bleeding disorder can be attributed to factors in plasma. Arterioscler Thromb 1991;11:733-44.
65. Turitto VT, Weiss HJ. Red blood cells: their dual role in thrombus formation. Science 1980;207:541-3.
66. Reimers RC, Sutera SP, Joist JH. Potentiation by red blood cells of shear-induced platelet aggregation: relative importance of chemical and physical mechanisms. Blood 1984;64:1200-6.
67. Harrison MJ, Pollock SS, Weisblatt E. Haematocrit and platelet aggregation (letter). Lancet 1984;1:991-2.
68. Alkhamis TM, Beissinger RL, Chediak JR. Effect of red blood cells on platelet adhesion and aggregation in low-stress shear flow. ASAIO Trans 1987;10:636-42.
69. Alkhamis TM, Beissinger RL, Chediak JR. Red blood cell effect on platelet adhesion and aggregation in low-stress shear flow. Myth or fact? ASAIO Trans 1988;34:868-73.
70. Bell DN, Spain S, Goldsmith HL. The effect of red blood cells on the ADP-induced aggregation of human platelets in flow through tubes. Thromb Haemost 1990;63:112-21.
71. Alkhamis TM, Beissinger RL, Chediak JR. Artificial surface effect on red blood cells and platelets in laminar shear flow. Blood 1990;75:1568-75.
72. Santos MT, Valles J, Marcus AJ, et al. Enhancement of platelet reactivity and modulation of eicosanoid production by intact erythrocytes. A new approach to platelet activation and recruitment. J Clin Invest 1991;87:571-80.
73. Saniabadi AR, Lowe GD, Barbenel JC, Forbes CD. Further studies on the role of red blood cells in spontaneous platelet aggregation. Thromb Res 1985;38:225-32.
74. Saniabadi AR, Lowe GDO, Madhok R, et al. Red blood cells mediate spontaneous aggregation of platelets in whole blood. Atherosclerosis 1987;66:175-80.
75. Luthje J. Extracellular adenosine compounds, red blood cells, and hemostasis: facts and hypothesis. Blut 1989;59:367-74.
76. Cattaneo M, Canciani MT, Lecchi A, et al. Released adenosine diphosphate stabilizes thrombin-induced human platelet aggregates. Blood 1990;75:1081-6.
77. Valles J, Santos MT, Aznar J, et al. Erythrocytes metabolically enhance collagen-induced platelet responsiveness via increased thromboxane production, adenosine diphosphate release, and recruitment. Blood 1991;78:154-62.
78. Marcus AJ. Thrombosis and inflammation as multicellular processes: pathophysiologic significance of transcellular metabolisms. Blood 1990;76:1903-7.
79. Valeri CR, MacGregor H, Cassidy G, et al. Effects of temperature on bleeding time and clotting time in normal male and female volunteers. Crit Care Med 1995;23:698-704.
80. Duke M, Abelmann WH. The hemodynamic response to chronic anemia. Circulation 1969;39:503-15.
81. Loscalzo J. Nitric oxide and vascular disease. N Engl J Med 1995;333:251-3.
82. Ignarro LJ, Buga GM, Wood KS, et al. Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. Proc Natl Acad Sci U S A 1987;84:9265-9.
83. Palmer RM, Ferrige AG, Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 1987;327:524-6.
84. Griffith TM, Edwards DH, Davies RL, et al. EDRF coordinates the behaviour of vascular resistance vessels. Nature 1987;329:442-5.
85. Cooke JP, Stamler JS, Andon N, et al. Flow stimulates endothelial cells to release a nitrovasodilator that is potentiated by reduced thiol. Am J Physiol 1990;259:H804-H812.
86. Radomski MW, Palmer RM, Moncada S. Endogenous nitric oxide inhibits human platelet adhesion to vascular endothelium. Lancet 1987;2:1057-8.
87. Azuma H, Ishikawa M, Sekizaki S. Endothelium-dependent inhibition of platelet aggregation. Br J Pharmacol 1986;88:411-5.
88. Mendelsohn ME, O'Neill S, George D, Loscalzo J. Inhibition of fibrinogen binding to human platelets by S-nitroso-N-acetylcysteine. J Biol Chem 1990;265:19028-34.
89. Michelson AD, Benoit SE, Furman MI, et al. Effects of endothelium-derived relaxing factor/nitric oxide on platelet surface glycoproteins. Am J Physiol 1996;270:1640-8.
90. Drabkin DL, Austin JH. Spectrophotometric studies. II. Preparations from washed blood cells; nitric oxide hemoglobin and sulfhemoglobin. J Biol Chem 1935;112:51-65.
91. Gibson QH, Roughton FJ. The kinetics and the equilibria of the reactions of nitric oxide with sheep hemoglobin. J Physiol Lond 1957;136:507-26.
92. Anand JS, Chandrashekhar Y, Wander GS, Chawla LS. Endothelium-derived relaxing factor is important in mediating the high output state in chronic severe anemia. J Am Coll Cardiol 1995;25:1402-7.
93. Crowley JP, Valeri CR, Metzger J, et al. The estimation of whole blood viscosity by a porous bed method. Am J Clin Pathol 1991;96:729-37.
94. McMahon LP, Dawborn JK. Subjective quality of life assessment in hemodialysis patients at different levels of hemoglobin following use of recombinant human erythropoietin. Am J Nephrol 1992;12:162-9.
95. Cazzola M, Mercuriali F, Brugnara C. Use of recombinant human erythropoietin outside the setting of uremia. Blood 1997;89:4248-67.
96. King LS. The blood-letting controversy: a study in the scientific method. Bull Hist Med 1961;35:1-13.
97. Greenwalt TJ. A short history of transfusion medicine. Transfusion 1997;37:550-63.
98. Krausz MM, Dennis RC, Utsunomiya T, et al. Cardiopulmonary function following transfusion of three red blood cell products in elective abdominal aortic aneurysmectomy. Ann Surg 1981;194:616-24.
99. Weisel RD, Dennis RC, Manny J, et al. Adverse effects of transfusion therapy during abdominal aortic aneurysectomy. Surgery 1978;83:682-90.
100. Cain SM. Oxygen delivery and uptake in dogs during anemic and hypoxic hypoxia. J Appl Physiol 1977;42:228-34.